HEADER HYDROLASE/HYDROLASE INHIBITOR 04-JAN-11 3Q70 TITLE SECRETED ASPARTIC PROTEASE IN COMPLEX WITH RITONAVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CANDIDAPEPSIN-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 57-398; COMPND 5 SYNONYM: ACP 2, ASPARTATE PROTEASE 2, SECRETED ASPARTIC PROTEASE 2; COMPND 6 EC: 3.4.23.24 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS; SOURCE 3 ORGANISM_COMMON: YEAST; SOURCE 4 ORGANISM_TAXID: 5476 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.KOESTER,A.HEINE,G.KLEBE REVDAT 2 13-SEP-23 3Q70 1 REMARK LINK REVDAT 1 04-JAN-12 3Q70 0 JRNL AUTH H.KOESTER,A.HEINE,G.KLEBE JRNL TITL THE BINDINGMODE OF HIV-1 PROTEASE INHIBITORS TO PEPSIN-LIKE JRNL TITL 2 ASPARTIC PROTEINASES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.175 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2987 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 59562 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.166 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 47275 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2464 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 210 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2734.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2379.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 8 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 11089 REMARK 3 NUMBER OF RESTRAINTS : 10591 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 ANGLE DISTANCES (A) : 0.028 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.061 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.055 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.034 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.054 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3Q70 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000063273. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : BERTELS MONOCHROMATOR WITH DUAL REMARK 200 CHANNEL CUT CRYSTALS (DCCM) IN (+ REMARK 200 --+) GEOMETRY REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62389 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 22.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1EAG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 9 MM ZNAC, 16% PEG 8000, 0.1M REMARK 280 IMIDAZOLE/MALATE BUFFER PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.64000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.22500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.73000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.22500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.64000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.73000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 284 REMARK 465 GLY A 285 REMARK 465 ASP A 286 REMARK 465 ASP A 287 REMARK 465 GLY A 288 REMARK 465 GLN A 289 REMARK 465 PRO A 290 REMARK 465 TYR A 291 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 GLN A 91 CG CD OE1 NE2 REMARK 470 ASP A 163 CG OD1 OD2 REMARK 470 ARG A 192 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 217 CG CD1 CD2 REMARK 470 LYS A 241 CG CD CE NZ REMARK 470 LYS A 268 CG CD CE NZ REMARK 470 ASN A 269 CG OD1 ND2 REMARK 470 ASP A 292 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 75 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 11 -44.09 80.13 REMARK 500 ASN A 160 -177.88 74.62 REMARK 500 ILE A 223 -160.34 -120.41 REMARK 500 ASN A 257 33.20 -99.50 REMARK 500 SER A 282 156.10 -45.35 REMARK 500 LEU A 297 47.99 -105.41 REMARK 500 ASN A 301 125.56 -170.19 REMARK 500 ASN A 304 76.10 57.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A3000 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 57 OD2 REMARK 620 2 HOH A6195 O 99.8 REMARK 620 3 HOH A6204 O 127.6 108.7 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A3001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A6196 O REMARK 620 2 HOH A6199 O 85.4 REMARK 620 3 HOH A6200 O 86.8 87.2 REMARK 620 4 HOH A6201 O 86.9 171.9 89.7 REMARK 620 5 HOH A6202 O 94.4 81.2 168.2 102.1 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: RITONAVIR REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 RIT A 2001 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 013 015 VAL 019 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RIT A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 3000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD A 4001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PRS RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN IN COMPLEX WITH RITONAVIR REMARK 900 RELATED ID: 3PWW RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN IN COMPLEX WITH SAQUINAVIR DBREF 3Q70 A 1 342 UNP P28871 CARP2_CANAL 57 398 SEQRES 1 A 342 GLN ALA VAL PRO VAL THR LEU HIS ASN GLU GLN VAL THR SEQRES 2 A 342 TYR ALA ALA ASP ILE THR VAL GLY SER ASN ASN GLN LYS SEQRES 3 A 342 LEU ASN VAL ILE VAL ASP THR GLY SER SER ASP LEU TRP SEQRES 4 A 342 VAL PRO ASP VAL ASN VAL ASP CYS GLN VAL THR TYR SER SEQRES 5 A 342 ASP GLN THR ALA ASP PHE CYS LYS GLN LYS GLY THR TYR SEQRES 6 A 342 ASP PRO SER GLY SER SER ALA SER GLN ASP LEU ASN THR SEQRES 7 A 342 PRO PHE LYS ILE GLY TYR GLY ASP GLY SER SER SER GLN SEQRES 8 A 342 GLY THR LEU TYR LYS ASP THR VAL GLY PHE GLY GLY VAL SEQRES 9 A 342 SER ILE LYS ASN GLN VAL LEU ALA ASP VAL ASP SER THR SEQRES 10 A 342 SER ILE ASP GLN GLY ILE LEU GLY VAL GLY TYR LYS THR SEQRES 11 A 342 ASN GLU ALA GLY GLY SER TYR ASP ASN VAL PRO VAL THR SEQRES 12 A 342 LEU LYS LYS GLN GLY VAL ILE ALA LYS ASN ALA TYR SER SEQRES 13 A 342 LEU TYR LEU ASN SER PRO ASP ALA ALA THR GLY GLN ILE SEQRES 14 A 342 ILE PHE GLY GLY VAL ASP ASN ALA LYS TYR SER GLY SER SEQRES 15 A 342 LEU ILE ALA LEU PRO VAL THR SER ASP ARG GLU LEU ARG SEQRES 16 A 342 ILE SER LEU GLY SER VAL GLU VAL SER GLY LYS THR ILE SEQRES 17 A 342 ASN THR ASP ASN VAL ASP VAL LEU LEU ASP SER GLY THR SEQRES 18 A 342 THR ILE THR TYR LEU GLN GLN ASP LEU ALA ASP GLN ILE SEQRES 19 A 342 ILE LYS ALA PHE ASN GLY LYS LEU THR GLN ASP SER ASN SEQRES 20 A 342 GLY ASN SER PHE TYR GLU VAL ASP CYS ASN LEU SER GLY SEQRES 21 A 342 ASP VAL VAL PHE ASN PHE SER LYS ASN ALA LYS ILE SER SEQRES 22 A 342 VAL PRO ALA SER GLU PHE ALA ALA SER LEU GLN GLY ASP SEQRES 23 A 342 ASP GLY GLN PRO TYR ASP LYS CYS GLN LEU LEU PHE ASP SEQRES 24 A 342 VAL ASN ASP ALA ASN ILE LEU GLY ASP ASN PHE LEU ARG SEQRES 25 A 342 SER ALA TYR ILE VAL TYR ASP LEU ASP ASP ASN GLU ILE SEQRES 26 A 342 SER LEU ALA GLN VAL LYS TYR THR SER ALA SER SER ILE SEQRES 27 A 342 SER ALA LEU THR HET RIT A2001 50 HET ZN A3000 1 HET ZN A3001 1 HET MRD A4001 8 HETNAM RIT RITONAVIR HETNAM ZN ZINC ION HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETSYN RIT A-84538 FORMUL 2 RIT C37 H48 N6 O5 S2 FORMUL 3 ZN 2(ZN 2+) FORMUL 5 MRD C6 H14 O2 FORMUL 6 HOH *210(H2 O) HELIX 1 1 ASP A 57 GLN A 61 5 5 HELIX 2 2 ASP A 66 SER A 70 5 5 HELIX 3 3 TYR A 128 GLU A 132 5 5 HELIX 4 4 ASN A 139 GLN A 147 1 9 HELIX 5 5 GLN A 227 PHE A 238 1 12 HELIX 6 6 GLY A 307 ARG A 312 1 6 SHEET 1 A 9 GLN A 74 GLY A 83 0 SHEET 2 A 9 SER A 89 PHE A 101 -1 O LEU A 94 N THR A 78 SHEET 3 A 9 TYR A 14 VAL A 20 -1 N THR A 19 O GLY A 100 SHEET 4 A 9 VAL A 3 ASN A 9 -1 N HIS A 8 O ALA A 15 SHEET 5 A 9 THR A 166 PHE A 171 -1 O ILE A 169 N VAL A 5 SHEET 6 A 9 ALA A 154 TYR A 158 -1 N TYR A 158 O GLN A 168 SHEET 7 A 9 ALA A 314 ASP A 319 -1 O TYR A 318 N TYR A 155 SHEET 8 A 9 GLU A 324 GLN A 329 -1 O GLU A 324 N ASP A 319 SHEET 9 A 9 ILE A 184 PRO A 187 -1 N LEU A 186 O ILE A 325 SHEET 1 B13 GLN A 74 GLY A 83 0 SHEET 2 B13 SER A 89 PHE A 101 -1 O LEU A 94 N THR A 78 SHEET 3 B13 VAL A 104 THR A 117 -1 O ILE A 106 N VAL A 99 SHEET 4 B13 LEU A 38 CYS A 47 1 N VAL A 40 O VAL A 114 SHEET 5 B13 ILE A 123 GLY A 125 -1 O ILE A 123 N TRP A 39 SHEET 6 B13 GLN A 25 ASP A 32 1 N ILE A 30 O LEU A 124 SHEET 7 B13 TYR A 14 VAL A 20 -1 N ILE A 18 O LEU A 27 SHEET 8 B13 VAL A 3 ASN A 9 -1 N HIS A 8 O ALA A 15 SHEET 9 B13 THR A 166 PHE A 171 -1 O ILE A 169 N VAL A 5 SHEET 10 B13 ALA A 154 TYR A 158 -1 N TYR A 158 O GLN A 168 SHEET 11 B13 ALA A 314 ASP A 319 -1 O TYR A 318 N TYR A 155 SHEET 12 B13 GLU A 324 GLN A 329 -1 O GLU A 324 N ASP A 319 SHEET 13 B13 ILE A 184 PRO A 187 -1 N LEU A 186 O ILE A 325 SHEET 1 C 2 GLY A 173 ASP A 175 0 SHEET 2 C 2 ILE A 338 ALA A 340 -1 O SER A 339 N VAL A 174 SHEET 1 D 7 LYS A 271 PRO A 275 0 SHEET 2 D 7 ASP A 261 ASN A 265 -1 N PHE A 264 O ILE A 272 SHEET 3 D 7 ARG A 195 VAL A 203 -1 N SER A 200 O ASN A 265 SHEET 4 D 7 LYS A 206 LEU A 217 -1 O ILE A 208 N VAL A 201 SHEET 5 D 7 ILE A 305 LEU A 306 1 O LEU A 306 N LEU A 216 SHEET 6 D 7 THR A 224 LEU A 226 -1 N TYR A 225 O ILE A 305 SHEET 7 D 7 PHE A 298 VAL A 300 1 O ASP A 299 N THR A 224 SHEET 1 E 4 LYS A 241 GLN A 244 0 SHEET 2 E 4 SER A 250 ASP A 255 -1 O PHE A 251 N THR A 243 SHEET 3 E 4 LYS A 293 LEU A 296 -1 O LEU A 296 N TYR A 252 SHEET 4 E 4 ALA A 280 ALA A 281 -1 N ALA A 281 O GLN A 295 SSBOND 1 CYS A 47 CYS A 59 1555 1555 2.09 SSBOND 2 CYS A 256 CYS A 294 1555 1555 2.03 LINK OD2 ASP A 57 ZN ZN A3000 1555 1555 2.01 LINK ZN ZN A3000 O HOH A6195 1555 1555 1.93 LINK ZN ZN A3000 O HOH A6204 1555 1555 1.99 LINK ZN ZN A3001 O HOH A6196 1555 1555 2.21 LINK ZN ZN A3001 O HOH A6199 1555 1555 2.20 LINK ZN ZN A3001 O HOH A6200 1555 1555 2.10 LINK ZN ZN A3001 O HOH A6201 1555 1555 2.04 LINK ZN ZN A3001 O HOH A6202 1555 1555 2.04 SITE 1 AC1 18 ASP A 32 GLY A 34 SER A 35 GLY A 83 SITE 2 AC1 18 TYR A 84 GLY A 85 ILE A 119 ASP A 120 SITE 3 AC1 18 ASN A 131 ASP A 218 GLY A 220 THR A 221 SITE 4 AC1 18 THR A 222 TYR A 225 ILE A 305 HOH A6004 SITE 5 AC1 18 HOH A6106 HOH A6173 SITE 1 AC2 4 ASP A 57 GLU A 324 HOH A6195 HOH A6204 SITE 1 AC3 5 HOH A6196 HOH A6199 HOH A6200 HOH A6201 SITE 2 AC3 5 HOH A6202 SITE 1 AC4 5 LEU A 183 SER A 326 HOH A6024 HOH A6058 SITE 2 AC4 5 HOH A6137 CRYST1 49.280 65.460 98.450 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020292 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015277 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010157 0.00000